Novavax Covid-19 vaccine

  • Novavax Covid-19 vaccine found 89.3% effective
    New York, January 29 (IANS): US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3 per cent effective in preventing Covid-19 in a trial conducted in the UK. The study assessed efficacy of the vaccine -- NVX-CoV2373 -- during a period with high transmission and with a new UK variant strain of the virus emerging and circulating widely. "NVX-CoV2373 has the potential to play an important role in solving this global public health crisis. W